EU approves two sites for making Pfizer's COVID-19 vaccine

A vial and sryinge are seen in entrance of a displayed Pfizer brand on this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration

Oct 18 (Reuters) – Europe’s drug regulator said on Monday it has accredited two extra manufacturing websites for producing the COVID-19 vaccine developed by Pfizer Inc (22UAy.DE), whereas additionally approving a ready-to-use formulation of the coronavirus shot.

Reporting by Pushkala Aripaka in Bengaluru; Modifying by Shounak Dasgupta

Our Requirements: The Thomson Reuters Trust Principles.

Source link